> Details

Schlenk, R.; Dombret, H.; Amadori, S.; Montesinos, P.; Levis, M.; Sekeres, M.A.; Cortes, J.; Perl, A.; Zernovak, O.; Mires, D.; Ge, N.; Zhang, H.; Hanyok, J.; Macintyre, S.; Gökmen, S.; Kobayashi, K.; Erba, H.

QuANTUM-First: phase 3, double-blind, placebo-controlled study of quizartinib in combination with induction and consolidation chemotherapy, and as maintenance therapy in patients (pts) with newly diagnosed (NDx) FLT3-ITD acute myeloid leukemia (AML)

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: QuANTUM-First: phase 3, double-blind, placebo-controlled study of quizartinib in combination with induction and consolidation chemotherapy, and as maintenance therapy in patients (pts) with newly diagnosed (NDx) FLT3-ITD acute myeloid leukemia (AML)
  • Contributor: Schlenk, R.; Dombret, H.; Amadori, S.; Montesinos, P.; Levis, M.; Sekeres, M.A.; Cortes, J.; Perl, A.; Zernovak, O.; Mires, D.; Ge, N.; Zhang, H.; Hanyok, J.; Macintyre, S.; Gökmen, S.; Kobayashi, K.; Erba, H.
  • imprint: Elsevier BV, 2017
  • Published in: Annals of Oncology
  • Language: English
  • DOI: 10.1093/annonc/mdx373.046
  • ISSN: 0923-7534
  • Keywords: Oncology ; Hematology
  • Origination:
  • Footnote:
  • Access State: Open Access